Abstract
(Abstracted from Int Urogynecol J 2018;29:1213–1219) First-line therapy for overactive bladder (OAB) includes an anticholinergic (ACH) medication and behavioral modification. There are high rates of discontinuation with ACH because of adverse effects such as dry mouth, dry eyes, and constipation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
